米兰系统在儿童涎腺细胞学中的应用:单中心细胞-组织学对照研究
本研究回顾某儿童医院15年间32例18岁及以下患者的涎腺细针穿刺(FNA)标本,按米兰系统(MSRSGC)重新分类并与手术病理对照。结果显示MSRSGC在儿童中敏感性100%、特异性80%,总恶性风险6%;切除病例中55%为肿瘤,良性肿瘤多于恶性。
要点
- 儿童涎腺FNA以良性病变为主,但切除病例中55%为肿瘤。
- MSRSGC在儿童中敏感性100%、特异性80%,总恶性风险6%。
- 需警惕IgG4相关涎腺炎及涎腺邻近皮肤软组织病变的鉴别。
核心结论
- MSRSGC在儿童涎腺FNA中应用表现较好,总恶性风险低(6%)且敏感性高。
研究设计与样本
- 回顾性单中心研究,检索15年间18岁及以下患者涎腺FNA共32例,按MSRSGC分类并与手术病理对照。
主要发现
- 32例平均年龄12岁(范围0.6-18岁),84.4%来自腮腺区。
- MSRSGC分类:良性肿瘤34%、非肿瘤性31%、无法诊断16%、意义不明异型性9%、恶性潜能未定涎腺肿瘤3%、可疑恶性3%、恶性3%。
- 总体敏感性100%、特异性80%,总恶性风险6%。
关键数值与推荐
- MSRSGC分类占比:良性肿瘤34%、非肿瘤性31%、无法诊断16%、意义不明异型性9%、恶性潜能未定涎腺肿瘤3%、可疑恶性3%、恶性3%。
- 切除随访中肿瘤占55%,其中多形性腺瘤6例(55%)、毛母质瘤3例(28%)、黏液表皮样癌1例(9%)、神经鞘瘤1例(9%)、肌纤维瘤1例(9%)。
- 敏感性100%、特异性80%,总恶性风险6%。
临床怎么用
- 儿童涎腺FNA可参照MSRSGC分类进行风险分层,但需注意儿童病变谱与成人不同。
- 对炎症性病变(如IgG4相关涎腺炎)及涎腺邻近皮肤软组织病变应保持鉴别意识。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) provides a useful framework for the diagnosis of salivary gland fine-needle aspiration (FNA) biopsies. In this study, the MSRSGC was applied to salivary gland FNAs in pediatric patients to assess its usefulness and look at pitfalls. METHODS: The laboratory information system was queried over a 15-year period for all salivary gland FNAs in patients 18 years old or younger. Patient demographics, FNA diagnosis categorized according to the MSRSGC, and follow-up surgical pathology diagnoses were examined and correlated. RESULTS: Thirty-two cases were identified, with an average age of 12 years (range, 0.6-18 years). A majority of the cases (84.4%) were from the parotid region. Twenty of 32 cases (62.5%) had follow-up resection. MSRSGC recategorization diagnoses of the 32 FNA cases were 34% benign neoplasm, 31% nonneoplastic, 16% nondiagnostic, 9% atypia of undetermined significance, 3% salivary neoplasm of uncertain malignant potential, 3% suspicious for malignancy, and 3% malignant. Overall, the sensitivity and specificity were 100% and 80%, respectively. On follow-up resection, 55% were neoplastic: pleomorphic adenomas (n = 6; 55%), pilomatricoma (n = 3; 28%), mucoepidermoid carcinoma (n = 1; 9%), schwannoma (n = 1; 9%), and myofibroma (n = 1; 9%). CONCLUSIONS: The MSRSGC performed fairly well in the pediatric population with a low overall risk of malignancy (6%) and high sensitivity. Although the majority of pediatric salivary gland FNAs were benign, 55% of resected cases were positive for a neoplasm, with benign neoplasms outnumbering malignancy. Challenging entities included inflammatory conditions, like immunoglobulin G4-related sialadenitis, and skin and soft tissue lesions near the salivary gland.
引用
- Satturwar SP, Fuller MY, Monaco SE, et al. Is Milan for kids?: The Milan System for Reporting Salivary Gland Cytology in pediatric patients at an academic children's hospital with cytologic-histologic correlation. Cancer Cytopathol. 2021. PMID: 34076955. doi:10.1002/cncy.22455
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。